$HCMC
Healthier Choices Management Corp. Stock $hcmc

$hcmc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224018493 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$15.59M	$15.89M	$13.56M
YoY Change	14.88%	17.22%	168.59%
Cost Of Revenue	$9.698M	$9.840M	$8.645M
YoY Change	14.19%	13.82%	181.05%
Gross Profit	$5.897M	$6.054M	$4.914M
YoY Change	16.04%	23.2%	149.14%
Gross Profit Margin	37.81%	38.09%	36.24%
Selling, General & Admin	$8.345M	$8.859M	$6.897M
YoY Change	1.01%	28.44%	107.29%
% of Gross Profit	141.51%	146.32%	140.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$138.0K	$139.0K	$142.6K
YoY Change	-63.1%	-2.5%	-26.26%
% of Gross Profit	2.34%	2.3%	2.9%
Operating Expenses	$8.345M	$8.859M	$6.897M
YoY Change	1.01%	28.44%	107.29%
Operating Profit	-$2.448M	-$2.805M	-$1.983M
YoY Change	-23.01%	41.43%	46.36%
Interest Expense	-$62.57K	-$59.85K	$93.19K
YoY Change	-164.3%	-164.22%	363.4%
% of Operating Profit
Other Income/Expense, Net	-$58.74K	-$56.49K	$75.75K
YoY Change	-113.67%	-174.58%	104.77%
Pretax Income	-$2.507M	-$2.861M	-$1.907M
YoY Change	-5.51%	50.01%	44.72%
Income Tax
% Of Pretax Income
Net Earnings	-$2.507M	-$2.861M	-$1.907M
YoY Change	-8.66%	50.01%	44.72%
Net Earnings / Revenue	-16.07%	-18.0%	-14.07%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	479.3B shares	478.3B shares	346.3B
Diluted Shares Outstanding	479.1B shares	478.3B shares	341.7B

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.353M	$3.905M	$19.77M
YoY Change	-60.47%	-80.25%	-4.09%
Cash & Equivalents	$3.353M	$3.905M	$21.49M
Short-Term Investments			$5.310K
Other Short-Term Assets	$97.14K	$86.26K	$944.5K
YoY Change	-96.05%	-90.87%	216.13%
Inventory	$3.997M	$4.177M	$3.967M
Prepaid Expenses
Receivables	$157.3K	$166.3K	$100.6K
Other Receivables	$0.00	$0.00	$172.9K
Total Short-Term Assets	$11.04M	$11.42M	$27.26M
YoY Change	-26.18%	-58.1%	15.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.078M	$2.174M	$3.097M
YoY Change	-84.73%	-29.81%	-53.76%
Goodwill			$5.747M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$579.4K	$632.0K	$475.4K
YoY Change	20.35%	32.94%	321.18%
Total Long-Term Assets	$16.57M	$17.71M	$25.10M
YoY Change	-32.03%	-29.43%	111.26%
TOTAL ASSETS
Total Short-Term Assets	$11.04M	$11.42M	$27.26M
Total Long-Term Assets	$16.57M	$17.71M	$25.10M
Total Assets	$27.61M	$29.13M	$52.36M
YoY Change	-29.81%	-44.36%	47.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.853M	$7.108M	$4.977M
YoY Change	52.98%	42.82%	141.75%
Accrued Expenses	$2.705M	$2.774M	$2.036M
YoY Change	37.62%	36.24%	235.42%
Deferred Revenue	$123.4K	$179.9K	$200.4K
YoY Change	-16.34%	-10.21%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.949M	$2.885M	$543.9K
YoY Change	193.32%	430.45%	19.32%
Total Short-Term Liabilities	$13.63M	$12.95M	$9.008M
YoY Change	58.05%	43.74%	167.65%
LONG-TERM LIABILITIES
Long-Term Debt	$2.036M	$2.221M	$2.239M
YoY Change	-2.93%	-0.79%	1599217.14%
Other Long-Term Liabilities	$7.182M	$7.827M	$8.657M
YoY Change	-14.45%	-9.59%	108.46%
Total Long-Term Liabilities	$2.036M	$2.221M	$2.239M
YoY Change	-80.59%	-0.79%	-46.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.63M	$12.95M	$9.008M
Total Long-Term Liabilities	$2.036M	$2.221M	$2.239M
Total Liabilities	$22.85M	$23.00M	$19.90M
YoY Change	19.52%	15.54%	164.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$67.46M	-$64.96M	-$45.52M
YoY Change	40.04%	42.7%
Common Stock	$47.93M	$47.83M	$34.64M
YoY Change	3.45%	38.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.652M	$5.024M	$18.96M
YoY Change
Total Liabilities & Shareholders Equity	$27.61M	$29.13M	$52.36M
YoY Change	-29.81%	-44.36%	47.76%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$2.507M	-$2.861M	-$1.907M
YoY Change	-8.66%	50.01%	44.72%
Depreciation, Depletion And Amortization	$138.0K	$139.0K	$142.6K
YoY Change	-63.1%	-2.5%	-26.26%
Cash From Operating Activities	-$97.30K	-$2.374M	-$2.344M
YoY Change	-92.6%	1.27%	244.94%
INVESTING ACTIVITIES
Capital Expenditures	$42.75K	$121.4K	$126.3K
YoY Change	96.28%	-3.84%	-199.19%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$16.32K
YoY Change		-100.0%	-100.32%
Cash From Investing Activities	-$42.75K	-$121.4K	-$109.9K
YoY Change	726.89%	10.44%	-97.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-411.4K	$1.319M	-742.2K
YoY Change	-96.28%	-277.75%	-2247.47%
NET CHANGE
Cash From Operating Activities	-97.30K	-$2.374M	-2.344M
Cash From Investing Activities	-42.75K	-$121.4K	-109.9K
Cash From Financing Activities	-411.4K	$1.319M	-742.2K
Net Change In Cash	-551.5K	-$1.176M	-3.196M
YoY Change	-95.55%	-63.2%	-45.9%
FREE CASH FLOW
Cash From Operating Activities	-$97.30K	-$2.374M	-$2.344M
Capital Expenditures	$42.75K	$121.4K	$126.3K
Free Cash Flow	-$140.1K	-$2.496M	-$2.471M
YoY Change	-89.52%	1.01%	347.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Conversions Inducements PreferredStockConversionsInducements		usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2023Q1	HCMC	Amortization Of Debt Discount And Noncash Interest Expense AmortizationOfDebtDiscountAndNoncashInterestExpense		usd
CY2024Q1	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable		usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2023Q1	HCMC	Proceeds From Security Purchase Agreement ProceedsFromSecurityPurchaseAgreement		usd
CY2024Q1	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock		usd
CY2024Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	HCMC	Non Cash Deferred Offering Cost NonCashDeferredOfferingCost		usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1		usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2024Q1	HCMC	Accrued Payment Of Induced Conversions Of Preferred Stock AccruedPaymentOfInducedConversionsOfPreferredStock		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-36469
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	HEALTHIER CHOICES MANAGEMENT CORP.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1070932
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3800 North 28th Way
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hollywood
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33020
CY2024Q1	dei	City Area Code CityAreaCode	305
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	600-5004
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	HCMC
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	479266632384	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5081086	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	128171	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4228889	usd
CY2023Q4	HCMC	Prepaid Expense And Vendor Deposits Current PrepaidExpenseAndVendorDepositsCurrent	1668324	usd
CY2024Q1	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	543854	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	65556	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	553232	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	11725258	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2735252	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4376682	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11511002	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	621385	usd
CY2023Q4	us-gaap	Assets Assets	30969579	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8024664	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	207513	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	453232	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	702701	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2842829	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12230939	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	2403807	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8465617	usd
CY2023Q4	us-gaap	Liabilities Liabilities	23100363	usd
CY2024Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	1000
CY2024Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	14722	shares
CY2024Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1111	shares
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1111	shares
CY2024Q1	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	1100000	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1111100	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	478266632384	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	478266632384	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	47826663	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21028274	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62096821	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6758116	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30969579	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15894477	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13559744	usd
CY2024Q1	HCMC	Cost Of Goods And Services Sold Sales Vapor CostOfGoodsAndServicesSoldSalesVapor	132	usd
CY2023Q1	HCMC	Cost Of Goods And Services Sold Sales Vapor CostOfGoodsAndServicesSoldSalesVapor	653	usd
CY2024Q1	HCMC	Cost Of Goods And Services Sold Sales Grocery CostOfGoodsAndServicesSoldSalesGrocery	9839981	usd
CY2023Q1	HCMC	Cost Of Goods And Services Sold Sales Grocery CostOfGoodsAndServicesSoldSalesGrocery	8644700	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	6054364	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	4914391	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	8859017	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6897438	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-857	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4457	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3355	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17450	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-58992	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	97653	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-56494	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	75746	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2861147	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1907301	usd
CY2023Q1	us-gaap	Preferred Stock Conversions Inducements PreferredStockConversionsInducements	61000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2861147	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1968301	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	478266632384	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	478266632384	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	341671076830	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	341671076830	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	6758116	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1126751	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2861147	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	5023720	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20206024	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20206024	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	670000	usd
CY2023Q1	us-gaap	Preferred Stock Conversions Inducements PreferredStockConversionsInducements	61000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1907301	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	18957723	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	18957723	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2861147	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1907301	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	379547	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	373462	usd
CY2024Q1	HCMC	Amortization Of Debt Discount And Noncash Interest Expense AmortizationOfDebtDiscountAndNoncashInterestExpense	18841	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-857	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4457	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	743247	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	695192	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	743419	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	523087	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1126751	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	50000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	22100	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38102	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	44818	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	691599	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	673392	usd
CY2024Q1	HCMC	Increase Decrease In Prepaid Expense And Vendor Deposits IncreaseDecreaseInPrepaidExpenseAndVendorDeposits	-362117	usd
CY2023Q1	HCMC	Increase Decrease In Prepaid Expense And Vendor Deposits IncreaseDecreaseInPrepaidExpenseAndVendorDeposits	255387	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	20701	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-279701	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	11496	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-771	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1391690	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-744145	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-27597	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1766	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-706560	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-669803	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2374113	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2344310	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	16320	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	121405	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	126251	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-121405	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-109931	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	209015	usd
CY2024Q1	HCMC	Proceeds From Security Purchase Agreement ProceedsFromSecurityPurchaseAgreement	1700000	usd
CY2024Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	171752	usd
CY2023Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	131614	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock	55000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	555550	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1319233	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-742164	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1176285	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3196405	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5634318	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24690124	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4458033	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21493719	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	104505	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	44478	usd
CY2024Q1	HCMC	Non Cash Deferred Offering Cost NonCashDeferredOfferingCost	475101	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	670000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1093290	usd
CY2023Q1	HCMC	Accrued Payment Of Induced Conversions Of Preferred Stock AccruedPaymentOfInducedConversionsOfPreferredStock	6000	usd
CY2024Q1	us-gaap	Number Of Stores NumberOfStores	3	store
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3900000	usd
CY2024Q1	HCMC	Working Capital Deficit WorkingCapitalDeficit	1500000	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	503000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	2516118	usd
CY2023Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	3814426	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3904801	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19765487	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	553232	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1728232	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4458033	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21493719	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15894477	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13559744	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15894477	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13559744	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2804653	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1983047	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	16533127	usd
CY2023Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1918800	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3834084	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4287679	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1660484	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1552427	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2173600	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2735252	usd
CY2024Q1	us-gaap	Depreciation Depreciation	139000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	143000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7528165	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3391827	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4136338	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7528165	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3151483	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4376682	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	240000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	231000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	719046	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	953891	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	875910	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	731489	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	412819	usd
CY2024Q1	HCMC	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	443183	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4136338	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1127000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	207513	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	198606	usd
CY2024Q1	HCMC	Contract With Customer Liability Issued ContractWithCustomerLiabilityIssued	706971	usd
CY2023	HCMC	Contract With Customer Liability Issued ContractWithCustomerLiabilityIssued	891060	usd
CY2024Q1	HCMC	Contract With Customer Liability Redeemed ContractWithCustomerLiabilityRedeemed	-671786	usd
CY2023	HCMC	Contract With Customer Liability Redeemed ContractWithCustomerLiabilityRedeemed	-812694	usd
CY2024Q1	HCMC	Contract With Customer Liability Breakage Recognized ContractWithCustomerLiabilityBreakageRecognized	-62782	usd
CY2023	HCMC	Contract With Customer Liability Breakage Recognized ContractWithCustomerLiabilityBreakageRecognized	-69459	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	179916	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	207513	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	4823645	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	3106508	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	170048	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	453232	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	453232	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	5106829	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	3559740	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2885367	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1155933	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2221462	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2403807	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	174288847200	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	209302000000	shares
CY2023Q4	us-gaap	Credit Derivative Maximum Exposure Undiscounted CreditDerivativeMaximumExposureUndiscounted	1500000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1500000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-018493-index-headers.html	Edgar Link	pending
0001493152-24-018493-index.html	Edgar Link	pending
0001493152-24-018493.txt	Edgar Link	pending
0001493152-24-018493-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
hcmc-20240331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
hcmc-20240331_cal.xml	Edgar Link	unprocessable
hcmc-20240331_def.xml	Edgar Link	unprocessable
hcmc-20240331_lab.xml	Edgar Link	unprocessable
hcmc-20240331_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCMC
Healthier Choices Management Corp. Stock $hcmc

2024 Q2 Form 10-Q Financial Statement

#000149315224018493 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCMC Healthier Choices Management Corp. Stock $hcmc

2024 Q2 Form 10-Q Financial Statement

#000149315224018493 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCMC
Healthier Choices Management Corp. Stock $hcmc